GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » Cyclically Adjusted Price-to-FCF

Syneos Health (FRA:8IN) Cyclically Adjusted Price-to-FCF : 15.50 (As of Apr. 27, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syneos Health Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Syneos Health's current share price is €40.00. Syneos Health's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 was €2.58. Syneos Health's Cyclically Adjusted Price-to-FCF for today is 15.50.

The historical rank and industry rank for Syneos Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:8IN' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 11.24   Med: 13.97   Max: 18.83
Current: 15.47

During the past years, Syneos Health's highest Cyclically Adjusted Price-to-FCF was 18.83. The lowest was 11.24. And the median was 13.97.

FRA:8IN's Cyclically Adjusted Price-to-FCF is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 33.84 vs FRA:8IN: 15.47

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Syneos Health's adjusted free cash flow per share data for the three months ended in Jun. 2023 was €-0.457. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €2.58 for the trailing ten years ended in Jun. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Syneos Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Syneos Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Cyclically Adjusted Price-to-FCF Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.63

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 18.24 12.63 12.32 14.93

Competitive Comparison of Syneos Health's Cyclically Adjusted Price-to-FCF

For the Diagnostics & Research subindustry, Syneos Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Syneos Health's Cyclically Adjusted Price-to-FCF falls into.



Syneos Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Syneos Health's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=40.00/2.58
=15.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Syneos Health's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2023 is calculated as:

For example, Syneos Health's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Jun. 2023 (Change)*Current CPI (Jun. 2023)
=-0.457/128.7287*128.7287
=-0.457

Current CPI (Jun. 2023) = 128.7287.

Syneos Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201309 0.000 98.790 0.000
201312 0.000 98.326 0.000
201403 0.370 99.695 0.478
201406 0.576 100.560 0.737
201409 0.475 100.428 0.609
201412 0.089 99.070 0.116
201503 0.568 99.621 0.734
201506 0.720 100.684 0.921
201509 0.636 100.392 0.816
201512 0.854 99.792 1.102
201603 -0.087 100.470 -0.111
201606 0.608 101.688 0.770
201609 0.728 101.861 0.920
201612 -0.003 101.863 -0.004
201703 1.105 102.862 1.383
201706 0.279 103.349 0.348
201709 -0.008 104.136 -0.010
201712 0.589 104.011 0.729
201803 -0.530 105.290 -0.648
201806 0.830 106.317 1.005
201809 0.960 106.507 1.160
201812 0.817 105.998 0.992
201903 -0.212 107.251 -0.254
201906 0.677 108.070 0.806
201909 0.448 108.329 0.532
201912 1.257 108.420 1.492
202003 -0.432 108.902 -0.511
202006 1.482 108.767 1.754
202009 1.187 109.815 1.391
202012 0.802 109.897 0.939
202103 0.923 111.754 1.063
202106 0.613 114.631 0.688
202109 0.332 115.734 0.369
202112 1.341 117.630 1.468
202203 0.412 121.301 0.437
202206 0.693 125.017 0.714
202209 1.081 125.227 1.111
202212 0.916 125.222 0.942
202303 0.026 127.348 0.026
202306 -0.457 128.729 -0.457

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Syneos Health  (FRA:8IN) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Syneos Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Syneos Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (FRA:8IN) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines